- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Buprenorphine Hydrochloride market will register a 8.9% CAGR in terms of revenue, the global market size will reach $ 571.9 million by 2025, from $ 406.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Buprenorphine Hydrochloride business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Hydrochloride market by type, application, key manufacturers and key regions and countries.
This study considers the Buprenorphine Hydrochloride value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Analgesic
Opioid Antagonist
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Siegfried
Rusan Pharma
Sanofi
Mallinckrodt
Noramco
Johnson Matthey
Resonance-labs
Unichemlabs
Sun Pharma
Arevipharma
Micro Orgo Chem
Faranshimi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Buprenorphine Hydrochloride consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Buprenorphine Hydrochloride market by identifying its various subsegments.
Focuses on the key global Buprenorphine Hydrochloride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Buprenorphine Hydrochloride with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Buprenorphine Hydrochloride submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Buprenorphine Hydrochloride Consumption 2015-2025
2.1.2 Buprenorphine Hydrochloride Consumption CAGR by Region
2.2 Buprenorphine Hydrochloride Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Buprenorphine Hydrochloride Consumption by Type
2.3.1 Global Buprenorphine Hydrochloride Consumption Market Share by Type (2015-2020)
2.3.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Type (2015-2020)
2.3.3 Global Buprenorphine Hydrochloride Sale Price by Type (2015-2020)
2.4 Buprenorphine Hydrochloride Segment by Application
2.4.1 Analgesic
2.4.2 Opioid Antagonist
2.5 Buprenorphine Hydrochloride Consumption by Application
2.5.1 Global Buprenorphine Hydrochloride Consumption Market Share by Type (2015-2020)
2.5.2 Global Buprenorphine Hydrochloride Value and Market Share by Type (2015-2020)
2.5.3 Global Buprenorphine Hydrochloride Sale Price by Type (2015-2020)
3 Global Buprenorphine Hydrochloride by Company
3.1 Global Buprenorphine Hydrochloride Sales Market Share by Company
3.1.1 Global Buprenorphine Hydrochloride Sales by Company (2018-2020)
3.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Company (2018-2020)
3.2 Global Buprenorphine Hydrochloride Revenue Market Share by Company
3.2.1 Global Buprenorphine Hydrochloride Revenue by Company (2018-2020)
3.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Company (2018-2020)
3.3 Global Buprenorphine Hydrochloride Sale Price by Company
3.4 Global Buprenorphine Hydrochloride Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Buprenorphine Hydrochloride Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Buprenorphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Buprenorphine Hydrochloride by Regions
4.1 Buprenorphine Hydrochloride by Regions
4.2 Americas Buprenorphine Hydrochloride Consumption Growth
4.3 APAC Buprenorphine Hydrochloride Consumption Growth
4.4 Europe Buprenorphine Hydrochloride Consumption Growth
4.5 Middle East & Africa Buprenorphine Hydrochloride Consumption Growth
5 Americas
5.1 Americas Buprenorphine Hydrochloride Consumption by Countries
5.1.1 Americas Buprenorphine Hydrochloride Consumption by Countries (2015-2020)
5.1.2 Americas Buprenorphine Hydrochloride Value by Countries (2015-2020)
5.2 Americas Buprenorphine Hydrochloride Consumption by Type
5.3 Americas Buprenorphine Hydrochloride Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Buprenorphine Hydrochloride Consumption by Regions
6.1.1 APAC Buprenorphine Hydrochloride Consumption by Regions (2015-2020)
6.1.2 APAC Buprenorphine Hydrochloride Value by Regions (2015-2020)
6.2 APAC Buprenorphine Hydrochloride Consumption by Type
6.3 APAC Buprenorphine Hydrochloride Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Buprenorphine Hydrochloride by Countries
7.1.1 Europe Buprenorphine Hydrochloride Consumption by Countries (2015-2020)
7.1.2 Europe Buprenorphine Hydrochloride Value by Countries (2015-2020)
7.2 Europe Buprenorphine Hydrochloride Consumption by Type
7.3 Europe Buprenorphine Hydrochloride Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Buprenorphine Hydrochloride by Countries
8.1.1 Middle East & Africa Buprenorphine Hydrochloride Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Buprenorphine Hydrochloride Value by Countries (2015-2020)
8.2 Middle East & Africa Buprenorphine Hydrochloride Consumption by Type
8.3 Middle East & Africa Buprenorphine Hydrochloride Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Buprenorphine Hydrochloride Distributors
10.3 Buprenorphine Hydrochloride Customer
11 Global Buprenorphine Hydrochloride Market Forecast
11.1 Global Buprenorphine Hydrochloride Consumption Forecast (2021-2025)
11.2 Global Buprenorphine Hydrochloride Forecast by Regions
11.2.1 Global Buprenorphine Hydrochloride Forecast by Regions (2021-2025)
11.2.2 Global Buprenorphine Hydrochloride Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Buprenorphine Hydrochloride Forecast by Type
11.8 Global Buprenorphine Hydrochloride Forecast by Application
12 Key Players Analysis
12.1 Siegfried
12.1.1 Company Information
12.1.2 Buprenorphine Hydrochloride Product Offered
12.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Siegfried Latest Developments
12.2 Rusan Pharma
12.2.1 Company Information
12.2.2 Buprenorphine Hydrochloride Product Offered
12.2.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Rusan Pharma Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Buprenorphine Hydrochloride Product Offered
12.3.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Mallinckrodt
12.4.1 Company Information
12.4.2 Buprenorphine Hydrochloride Product Offered
12.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Mallinckrodt Latest Developments
12.5 Noramco
12.5.1 Company Information
12.5.2 Buprenorphine Hydrochloride Product Offered
12.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Noramco Latest Developments
12.6 Johnson Matthey
12.6.1 Company Information
12.6.2 Buprenorphine Hydrochloride Product Offered
12.6.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Johnson Matthey Latest Developments
12.7 Resonance-labs
12.7.1 Company Information
12.7.2 Buprenorphine Hydrochloride Product Offered
12.7.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Resonance-labs Latest Developments
12.8 Unichemlabs
12.8.1 Company Information
12.8.2 Buprenorphine Hydrochloride Product Offered
12.8.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Unichemlabs Latest Developments
12.9 Sun Pharma
12.9.1 Company Information
12.9.2 Buprenorphine Hydrochloride Product Offered
12.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sun Pharma Latest Developments
12.10 Arevipharma
12.10.1 Company Information
12.10.2 Buprenorphine Hydrochloride Product Offered
12.10.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Arevipharma Latest Developments
12.11 Micro Orgo Chem
12.11.1 Company Information
12.11.2 Buprenorphine Hydrochloride Product Offered
12.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Micro Orgo Chem Latest Developments
12.12 Faranshimi
12.12.1 Company Information
12.12.2 Buprenorphine Hydrochloride Product Offered
12.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Faranshimi Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Buprenorphine Hydrochloride Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Pl
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
